Back to UBS Group AG UBS Group AG

BGLCBGLC
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in BIONEXUS GENE LAB CORP

UBS Group AG holds 101 shares of BGLC (BIONEXUS GENE LAB CORP), worth $197 as of 2026-Q2. The position was decreased (-56.3% shares).

Current Value

$197

Current Shares

101

Total Value Change

-$29,158

Total Shares Change

-9,461

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
101
-56.3%
$1970.0%$1.95
0
2026-Q1
New
231
-
$4950.0%$2.53
17
2025-Q4
Exited
0
-100.0%
$00.0%$3.95
0
2025-Q3
Decreased
7,626
-20.3%
$41,7140.0%$5.47
0
2025-Q2
New
9,562
-
$29,3550.0%$2.77
30

Other major holders of BGLC: HRT FINANCIAL LP, WELLS FARGO & COMPANY/MN

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used